White label ELPA - ClinicalTrials.eu

A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

Recruiting

2 1 1 1
Investigated Diseases:
- Hernia repair
Investigated Drugs:
- Botulinum Toxin Type A – Haemagglutinin Complex
Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

Recruiting

2 1 1 1
Investigated Drugs:
A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Oesophageal adenocarcinoma
Investigated Drugs:
A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

Recruiting

2 1 1
Investigated Drugs:
- Datopotamab Deruxtecan
Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

Recruiting

3 1 1 1
Investigated Diseases:
- Respiratory syncytial virus infection
A Study of BMS-986517 for Adults with Advanced Solid Tumors to Test Safety and Find the Best Dose

Recruiting

2 1 1
A Study Testing Cabergoline to Prevent and Treat Episodic Migraine in Patients with Recurring Migraine Headaches

Recruiting

3 1 1
Investigated Diseases:
- Migraine
Investigated Drugs:
- Cabergoline
A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

Recruiting

2 1 1

+1
A Study of GSK5458514 Alone or With Other Cancer Drugs in Adults With Metastatic Castration-Resistant Prostate Cancer

Recruiting

2 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- GSK5458514
A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

Recruiting

3 1 1
Investigated Diseases:
- Immune thrombocytopenia
+6

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies